Controlling Key Molecular Switches
     in Naturally Occurring Biological Pathways

ENDECE™ LLC is a biotechnology company with experienced leadership and an innovative approach to the discovery and development of small molecule drugs that control key molecular switches in naturally occurring biological pathways.

Featured News

Extending Focus:  Sepsis and memory are two new discovery platforms at ENDECE.
more >>

Moving Forward: ENDECE secures second round of funding.
more >>

Pipeline: Pre-clinical studies suggest NDC compounds from ENDECE are efficacious for many cancers.
more >>